Orion Corporation: Managers’ transactions – René Lindell

Group 1 - Orion Corporation has received a notification regarding transactions made by its Chief Financial Officer, René Lindell, under the Market Abuse Regulation [1] - The transaction involved the receipt of a share-based incentive, with a volume of 4,533 shares at a unit price of 0 EUR [1] - Orion Corporation's net sales in 2024 amounted to EUR 1,542 million, and the company employed approximately 3,700 people at the end of the year [2] Group 2 - Orion Corporation is a Finnish pharmaceutical company with over a hundred years of experience in developing, manufacturing, and marketing pharmaceuticals [2] - The company has a diverse portfolio that includes proprietary and generic medicines, as well as consumer health products, focusing on oncology and pain management [2] - Orion's shares are listed on Nasdaq Helsinki, with both A and B shares available for trading [2]